These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 9141511)
1. Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome. Schipper I; Rommerts FF; Ten Hacken PM; Fauser BC J Clin Endocrinol Metab; 1997 May; 82(5):1325-31. PubMed ID: 9141511 [TBL] [Abstract][Full Text] [Related]
2. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome. Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213 [TBL] [Abstract][Full Text] [Related]
3. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome. Catteau-Jonard S; Pigny P; Reyss AC; Decanter C; Poncelet E; Dewailly D J Clin Endocrinol Metab; 2007 Nov; 92(11):4138-43. PubMed ID: 17698904 [TBL] [Abstract][Full Text] [Related]
4. Application of a CHO cell line transfected with the human FSH receptor for the measurement of specific FSH receptor activation inhibitors in human serum. Schipper I; Fauser BC; ten Hacken PM; Rommerts FF J Endocrinol; 1996 Sep; 150(3):505-14. PubMed ID: 8882170 [TBL] [Abstract][Full Text] [Related]
5. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. Mason HD; Willis DS; Beard RW; Winston RM; Margara R; Franks S J Clin Endocrinol Metab; 1994 Nov; 79(5):1355-60. PubMed ID: 7962330 [TBL] [Abstract][Full Text] [Related]
6. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. Welt CK; Taylor AE; Fox J; Messerlian GM; Adams JM; Schneyer AL J Clin Endocrinol Metab; 2005 Oct; 90(10):5582-7. PubMed ID: 16030174 [TBL] [Abstract][Full Text] [Related]
7. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683 [TBL] [Abstract][Full Text] [Related]
8. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome. Das M; Gillott DJ; Saridogan E; Djahanbakhch O Hum Reprod; 2008 Sep; 23(9):2122-6. PubMed ID: 18550512 [TBL] [Abstract][Full Text] [Related]
9. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation. Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110 [TBL] [Abstract][Full Text] [Related]
11. 17 beta-Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals. Pache TD; Hop WC; de Jong FH; Leerentveld RA; van Geldorp H; Van de Kamp TM; Gooren LJ; Fauser BC Clin Endocrinol (Oxf); 1992 Jun; 36(6):565-71. PubMed ID: 1424181 [TBL] [Abstract][Full Text] [Related]
12. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age]. Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740 [TBL] [Abstract][Full Text] [Related]
13. A mechanism for the suppression of estrogen production in polycystic ovary syndrome. Agarwal SK; Judd HL; Magoffin DA J Clin Endocrinol Metab; 1996 Oct; 81(10):3686-91. PubMed ID: 8855823 [TBL] [Abstract][Full Text] [Related]
14. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization. Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798 [TBL] [Abstract][Full Text] [Related]
15. Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome. Magoffin DA; Jakimiuk AJ Hum Reprod; 1998 Oct; 13(1O):2693-8. PubMed ID: 9804215 [TBL] [Abstract][Full Text] [Related]
16. Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference? Burgers JA; Fong SL; Louwers YV; Valkenburg O; de Jong FH; Fauser BC; Laven JS J Clin Endocrinol Metab; 2010 Dec; 95(12):E485-9. PubMed ID: 20843954 [TBL] [Abstract][Full Text] [Related]
18. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. Pellatt L; Hanna L; Brincat M; Galea R; Brain H; Whitehead S; Mason H J Clin Endocrinol Metab; 2007 Jan; 92(1):240-5. PubMed ID: 17062765 [TBL] [Abstract][Full Text] [Related]
19. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women. Wachs DS; Coffler MS; Malcom PJ; Chang RJ J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061 [TBL] [Abstract][Full Text] [Related]
20. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries. Elting MW; Kwee J; Schats R; Rekers-Mombarg LT; Schoemaker J J Clin Endocrinol Metab; 2001 Apr; 86(4):1589-95. PubMed ID: 11297588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]